India Moves To Make HIV/AIDS Drugs More Available
This article was originally published in PharmAsia News
Executive Summary
India is the third-largest country for HIV-positive cases, yet its policy of free drugs to HIV/AIDS patients is not being fulfilled because of the vast distances patients have to travel. Many patients give up treatment because of the distances between places where the drugs are available and the cost of getting to them, even though the country has 147 centers for providing antiretroviral therapy. Some patients have to travel long, arduous distances three times a month for treatment. As a result, the Indian government is looking at "link centers" to bring treatment closer to the patients who need it. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.